Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat

Afford, 2000, Demystified…: apoptosis, Mol. Pathol., 53, 55, 10.1136/mp.53.2.55 Anglade, 1997, Apoptosis and autophagy in nigral neurons of patients with Parkinson’s disease, Histol. Histopathol., 12, 25 Banati, 1998, Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson’s disease, Mov. Disord., 13, 221, 10.1002/mds.870130205 Burke, 1998, Programmed cell death: does it play a role in Parkinson’s disease?, Ann. Neurol., 44, S126, 10.1002/ana.410440719 Croker, 2001, NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6-OHDA rat model of Parkinson’s disease, Eur. J. Neurosci., 14, 391, 10.1046/j.0953-816x.2001.01653.x Curtius, 1974, Mass fragmentography of dopamine and 6-hydroxydopamine. Application to the determination of dopamine in human brain biopsies from the caudate nucleus, J. Chromatogr., 99, 529, 10.1016/S0021-9673(00)90882-3 Cutillas, 1999, Caspase inhibition protects nigral neurons against 6-OHDA-induced retrograde degeneration, NeuroReport, 10, 2605, 10.1097/00001756-199908200-00030 Desmukh, 1997, Programmed cell death in neurons: focus on the pathway of nerve growth factor deprivation-induced death of sympathetic neurons, Mol. Pharmacol., 51, 897, 10.1124/mol.51.6.897 Dragunow, 1995, In situ evidence for DNA fragmentation in Huntington’s disease striatum and Alzheimer’s disease temporal lobes, NeuroReport, 6, 1053, 10.1097/00001756-199505090-00026 He, 2000, 6-Hydroxydopamine induced apoptosis of dopaminergic cells in the rat substantia nigra, Brain Res., 858, 163, 10.1016/S0006-8993(99)02459-2 Hokfelt, 1973, Specificity of 6-hydroxydopamine induced degeneration of central monoamine neurones: an electron and fluorescence microscopic study with special reference to intracerebral injection on the nigro-striatal dopamine system, Brain Res., 60, 269, 10.1016/0006-8993(73)90791-9 Honig, 2000, Apoptosis and neurologic disease, Am. J. Med., 198, 317, 10.1016/S0002-9343(00)00291-6 Irwin, 1995, Endogenous toxins as potential etiological agents in Parkinson’s disease, 153 Jackson-Lewis, 2000, Developmental cell death in dopaminergic neurons of the substantia nigra of mice, J. Comp. Neurol., 424, 476, 10.1002/1096-9861(20000828)424:3<476::AID-CNE6>3.0.CO;2-0 Jellinger, 1995, Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson’s disease, J. Neural Transm. Suppl., 46, 297 Jellinger, 2000, Mechanisms of cell death in neurodegenerative disorders, J. Neural Transm. Suppl., 59, 95 Jeon, 1995, 6-Hydroxydopamine lesion of the rat substantia nigra: time-course and morphology of cell death, Neurodegeneration, 4, 131, 10.1006/neur.1995.0016 Kingsbury, 1998, DNA fragmentation in human substantia nigra: apoptosis or perimortem effect?, Mov. Disord., 13, 877, 10.1002/mds.870130604 Kosel, 1997, On the question of apoptosis in the parkinsonian substantia nigra, Acta Neuropathol., 93, 105, 10.1007/s004010050590 Lotharius, 1999, Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons, J. Neurosci., 19, 1284, 10.1523/JNEUROSCI.19-04-01284.1999 Marti, 1997, Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra, J. Neurosci., 17, 2030, 10.1523/JNEUROSCI.17-06-02030.1997 Mochizuki, 1996, Histochemical detection of apoptosis in Parkinson’s disease, J. Neurol. Sci., 137, 120, 10.1016/0022-510X(95)00336-Z Mogi, 2000, Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brain, J. Neural Transm., 107, 335, 10.1007/s007020050028 Nijhavan, 2000, Apoptosis in neural development and disease, Annu. Rev. Neurosci., 23, 73, 10.1146/annurev.neuro.23.1.73 Ochu, 1998, Caspases mediate 6-hydroxydopamine-induced apoptosis but not necrosis in PC12 cells, J. Neurochem., 70, 2637, 10.1046/j.1471-4159.1998.70062637.x Paxinos, 1986 Przedborski, 1995, Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine, Neuroscience, 67, 631, 10.1016/0306-4522(95)00066-R Saraste, 2000, Morphologic and biochemical hallmarks of apoptosis, Cardiovasc. Res., 45, 528, 10.1016/S0008-6363(99)00384-3 Sauer, 1994, Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat, Neuroscience, 59, 401, 10.1016/0306-4522(94)90605-X Schutte, 2000, Molecular switches that govern the balance between proliferation and apoptosis, Prog. Cell Cycle Res., 4, 207, 10.1007/978-1-4615-4253-7_18 Soto-Otero, 2000, Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson’s disease, J. Neurochem., 74, 1605, 10.1046/j.1471-4159.2000.0741605.x Tatton, 2000, Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson’s disease, Exp. Neurol., 166, 29, 10.1006/exnr.2000.7489 Tompkins, 1997, Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigra neurons, Am. J. Pathol., 150, 119 Walkinshaw, 1994, Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis, Neuroscience, 63, 975, 10.1016/0306-4522(94)90566-5 Wullner, 1999, Cell death and apoptosis regulating proteins in Parkinson’s disease—a cautionary note, Acta Neuropathol., 97, 408, 10.1007/s004010051005 Yamada, 1999, Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo, Proc. Natl. Acad. Sci. USA, 96, 4078, 10.1073/pnas.96.7.4078 Zuch, 2000, Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion, J. Comp. Neurol., 427, 440, 10.1002/1096-9861(20001120)427:3<440::AID-CNE10>3.0.CO;2-7